

Cover Story
NCI
By Alexandria Carolan
As the likelihood of a flat budget increases for the 2024 fiscal year, NCI will have difficulty maintaining its current programs, the institute’s new director Kimryn Rathmell said in her inaugural NCI director’s report to members of the National Cancer Advisory Board Feb. 8.
In Brief


Drugs & Targets
Trending Stories
- With Anthony Letai’s appointment, NCI is now under new leadership—just in time for a shutdown
- Dana-Farber/Harvard Cancer Center awarded $12M NIH SPORE grant to advance breast cancer research
- Anthony Letai sworn in as 18th NCI director
- U.S. government shuts down
Impact on NCI uncertain as administration threatens more RIFs - Former NCI official’s nonprofit seeks to tell the stories of cancer patients
Patient Action for Cancer Research aims to show impact of federal research - Sakaguchi, Ramsdell, Rudensky win Crafoord Prize for discoveries in immune regulation